A 36-week, single-arm, open-label study to evaluate the safety and tolerability of ferric citrate in children with hyperphosphatemia related to chronic kidney disease.
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/kidney-disease.jpg)
Description
A single arm trial evaluating efficacy of ferric citrate over 36 weeks in pediatric patients with hyperphosphatemia related to CKD.
Details
Age
Child
Eligibility
12-17 years old, diagnosis of CKD
Locations
Childrens Hospital Colorado
Principal Investigator
![Photograph of Weiwen Shih](https://som.ucdenver.edu/FIMS/Content/faculty/36081/CU-Doctors-36081.jpg)
Weiwen Shih
Study ID
Protocol Number: 23-0073
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers